Medpace Holdings, Inc. Reports First Quarter 2024 Results - 22.04.2024
Related Articles
-
Pfizer Reports First-Quarter 2024 Results
NEW YORK, May 01, 2024--Pfizer Inc. (NYSE: PFE) reported financial results for the first quarter of 2024 and raised its Adjusted(3) diluted EPS guidance while maintaining all other components of its 2024 financial guidance(6).
-
Aptar Reports First Quarter 2024 Results
Aptar Reports First Quarter 2024 Results. AptarGroup, Inc. (NYSE:ATR), a global leader in drug and consumer product dosing, dispensing and...
-
Dow reports first quarter 2024 results
GAAP earnings per share was $0.73; operating earnings per share (EPS)1 was $0.56, compared to $0.58 in the year-ago period and $0.43 in the...